ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Innovation Pharma to increase dosing frequency in Covid-19 drug trial
April 07, 2021Innovation Pharmaceuticals is set to increase dosing frequency in Phase II clinical trial of a drug candidate, Brilacidin, for treating moderate-to-severe Covid-19 in hospitalised patients. -
Apellis Will Not Peruse Development of APL-9 for Severe COVID-19
March 10, 2021Apellis Pharmaceuticals announced the company will not pursue additional development of APL-9, an investigational targeted C3 therapy designed for acute interventions, for the treatment of severe COVID-19. -
Regeneron to continue patient recruitment for Covid-19 trial
November 09, 2020The independent data monitoring committee (DMC) has recommended the continuation of Regeneron’s UK-based RECOVERY trial analysing REGN-COV2 in hospitalised patients with Covid-19. -
Independent DMC Recommends Trial Discontinuation of Staphylococcus aureus Vaccine
December 29, 2018Pfizer announced the Phase 2b trial STRIVE (STaphylococcus aureus SuRgical Inpatient Vaccine Efficacy) evaluating the company’s investigational Staphylococcus aureus (S. aureus) multi-antigen vaccine (PF-06290510) is being discontinued due to futility.... -
Legend Capital co-invests $293M in Chinese DMC
August 03, 2018Chinese Diagnostics Medical Corporation specializes in the design and development of diagnostic testing reagents.
Pharma Sources Insight January 2025
